Breaking News Instant updates and real-time market news.

2020-11-30 14:06:57 GNPX Genprex $3.14 / +0.05 (+1.62%) , AZN AstraZeneca $52.97 / +0.39 (+0.74%) 14:06 11/30/20 11/30 14:06 11/30/20 14:06	Genprex initiates site recruitment for Acclaim-1 clinical trial Genprex (GNPX) announced it has commenced clinical trial site recruitment for its upcoming Acclaim-1 clinical trial for the treatment of non-small cell lung cancer. As planned, the timing of the patient recruitment and enrollment puts the company on track for its Acclaim-1 clinical trial to commence in the first-half of 2021. Acclaim-1 is an open-label, multi-center Phase 1/2 clinical trial that combines Genprex's lead drug candidate, REQORSA immunogene therapy with AstraZeneca's (AZN) Tagrisso in patients with late stage NSCLC with mutated epidermal growth factor receptors, whose disease progressed after treatment with Tagrisso. Genprex received U.S. FDA Fast Track Designation for its Acclaim-1 patient population in January of 2020. "Our clinical team is engaging with prestigious cancer centers and research institutions across the U.S. to ensure we select optimal study sites, which play an important role in the success of a clinical trial," said Rodney Varner, President and CEO. The company plans to conduct the Acclaim-1 clinical trial in approximately 10 U.S. sites with about 100 patients. An interim analysis will be performed after 53 events. GNPX Genprex $3.14 / +0.05 (+1.62%) AZN AstraZeneca $52.97 / +0.39 (+0.74%)	05 Dec 08 Dec
GNPX AZN GNPX Genprex $3.14 / +0.05 (+1.62%) 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners AZN AstraZeneca $52.97 / +0.39 (+0.74%) 11/30/20 UBS AstraZeneca upgraded to Neutral from Sell at UBS 11/27/20 Argus AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus 11/27/20 Citi Citi opens 'positive catalyst watch' on AstraZeneca after vaccine selloff 11/24/20 Piper Sandler Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler

2020-11-30 14:06:57

GNPX

Genprex

$3.14 / +0.05 (+1.62%)

, AZN

AstraZeneca

$52.97 / +0.39 (+0.74%)

14:06

11/30/20

11/30

14:06

11/30/20

14:06

Genprex initiates site recruitment for Acclaim-1 clinical trial

Genprex (GNPX) announced it has commenced clinical trial site recruitment for its upcoming Acclaim-1 clinical trial for the treatment of non-small cell lung cancer. As planned, the timing of the patient recruitment and enrollment puts the company on track for its Acclaim-1 clinical trial to commence in the first-half of 2021. Acclaim-1 is an open-label, multi-center Phase 1/2 clinical trial that combines Genprex's lead drug candidate, REQORSA immunogene therapy with AstraZeneca's (AZN) Tagrisso in patients with late stage NSCLC with mutated epidermal growth factor receptors, whose disease progressed after treatment with Tagrisso. Genprex received U.S. FDA Fast Track Designation for its Acclaim-1 patient population in January of 2020. "Our clinical team is engaging with prestigious cancer centers and research institutions across the U.S. to ensure we select optimal study sites, which play an important role in the success of a clinical trial," said Rodney Varner, President and CEO. The company plans to conduct the Acclaim-1 clinical trial in approximately 10 U.S. sites with about 100 patients. An interim analysis will be performed after 53 events.

GNPX

Genprex

$3.14 / +0.05 (+1.62%)

AZN

AstraZeneca

$52.97 / +0.39 (+0.74%)

05
Dec
08
Dec

GNPX
AZN

GNPX Genprex

$3.14 / +0.05 (+1.62%)

04/22/20 Alliance Global Partners: Genprex initiated with a Buy at Alliance Global Partners

AZN AstraZeneca

$52.97 / +0.39 (+0.74%)

11/30/20 UBS: AstraZeneca upgraded to Neutral from Sell at UBS

11/27/20 Argus: AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus

11/27/20 Citi: Citi opens 'positive catalyst watch' on AstraZeneca after vaccine selloff

11/24/20 Piper Sandler: Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler

TODAY'S FREE FLY STORIES

Recommendations	Puma price target lowered to EUR 98 from EUR 100 at RBC Capital » 13:30 01/26/21 01/26 13:30 01/26/21 13:30 PUMSY Puma $0.00 / + (+0.00%) RBC Capital analyst Piral… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PUMSY Puma $0.00 / + (+0.00%) 05:35 Today Morgan Stanley Puma downgraded to Equal Weight from Overweight at Morgan Stanley 05:28 Today Baader Helvea Puma downgraded to Reduce from Add at Baader Helvea 01/25/21 JPMorgan Puma price target raised to EUR 95 from EUR 87 at JPMorgan 01/25/21 Credit Suisse Puma price target raised to EUR 86 from EUR 80 at Credit Suisse
Recommendations	Acciona price target raised to EUR 140 from EUR 115 at RBC Capital » 13:29 01/26/21 01/26 13:29 01/26/21 13:29 ACXIF Acciona $0.00 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ACXIF Acciona $0.00 / + (+0.00%) 01/12/21 Barclays Acciona downgraded to Equal Weight from Overweight at Barclays 06/05/20 Citi Acciona upgraded to Neutral from Sell at Citi 03/24/20 Citi Acciona downgraded to Sell from Buy at Citi 03/23/20 Goldman Sachs Acciona downgraded to Neutral from Buy at Goldman Sachs
Recommendations	Eurofins Scientific price target raised to EUR 80 from EUR 76 at Credit Suisse » 13:28 01/26/21 01/26 13:28 01/26/21 13:28 ERRFY Eurofins Scientific $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ERRFY Eurofins Scientific $0.00 / + (+0.00%) 12:49 Today Deutsche Bank Eurofins Scientific price target raised to EUR 55 from EUR 53 at Deutsche Bank 01/22/21 Stifel Eurofins Scientific downgraded to Hold from Buy at Stifel 12/16/20 Deutsche Bank Eurofins Scientific price target raised to EUR 53 from EUR 52 at Deutsche Bank 12/16/20 Citi Eurofins Scientific price target raised to EUR 67 from EUR 66 at Citi
Recommendations	Philips price target raised to EUR 45 from EUR 41 at Credit Suisse » 13:28 01/26/21 01/26 13:28 01/26/21 13:28 PHG Philips $57.67 / +0.68 (+1.19%) Credit Suisse analyst Max… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PHG Philips $57.67 / +0.68 (+1.19%) 01/25/21 Philips' Stellarex drug-coated balloon meets safety goals in two studies 01/25/21 Philips, Rennes University Hospital announce five-year partnership 01/25/21 Philips, Vithas Group enter five-year innovation and collaboration agreement 01/19/21 Philips to acquire Capsule Technologies for $635M in cash, sees accretion PHG Philips $57.67 / +0.68 (+1.19%) 13:20 Today JPMorgan Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan 12:45 Today UBS Philips price target raised to EUR 54 from EUR 51 at UBS 01/25/21 Morgan Stanley iRhythm price target raised to $288 from $227 at Morgan Stanley 01/20/21 Berenberg Philips price target raised to EUR 50 from EUR 49 at Berenberg PHG Philips $57.67 / +0.68 (+1.19%) 01/25/21 Philips reports Q4 adjusted EPS EUR 0.94 vs. EUR 0.83 last year 10/19/20 Philips reports Q3 adj. EPS EUR 0.60 vs. EUR 0.46 last year PHG Philips $57.67 / +0.68 (+1.19%) 01/05/21 Philips shortlists Asian suitors in home appliance unit sale, Bloomberg says PHG Philips $57.67 / +0.68 (+1.19%) 01/25/21 Fly Intel: Pre-market Movers 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers 03/02/21 2021 London Global Healthcare Virtual Conference
Recommendations	Engie SA price target raised to EUR 14.20 from EUR 13.50 at Credit Suisse » 13:27 01/26/21 01/26 13:27 01/26/21 13:27 ENGIY Engie SA $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals ENGIY Engie SA $0.00 / + (+0.00%) 12/11/20 TPG Pace Beneficial Finance soars after combination with EVBox Group 12/10/20 Engie SA announces several energy offtake contracts with Amazon.com 11/12/20 FCA, Engie EPS to establish e-mobility joint venture in Europe 10/05/20 Engie accepts Veolia's offer to purchase its stake in Suez ENGIY Engie SA $0.00 / + (+0.00%) 01/12/21 Barclays Engie SA price target raised to EUR 16 from EUR 15.50 at Barclays 01/12/21 Deutsche Bank Engie SA price target raised to EUR 14 from EUR 13 at Deutsche Bank 01/07/21 JPMorgan Engie SA price target raised to EUR 17 from EUR 16 at JPMorgan 12/18/20 Morgan Stanley Engie SA price target raised to EUR 16 from EUR 15 at Morgan Stanley ENGIY Engie SA $0.00 / + (+0.00%) 12/31/20 Engie SA under pressure amid plan to streamline operations, FT reports 12/02/20 Engie gathers advisers for $6B services disposal, Bloomberg reports 09/25/20 Veolia CEO to increase offer price for stake in Suez, Bloomberg reports

Options	Sorrento Therapeutics call volume above normal and directionally bullish » 13:25 01/26/21 01/26 13:25 01/26/21 13:25 SRNE Sorrento Therapeutics $10.27 / +0.98 (+10.55%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options SRNE Sorrento Therapeutics $10.27 / +0.98 (+10.55%) 01/19/21 Sorrento Therapeutics jumps 10% to $10.40 after COVID data announcement 01/19/21 Sorrento Therapeutics to present STI-2020 data from mutation survey in COVID 12/30/20 Sorrento submits Marketing Authorization Application to Mexico for COVI-STIX 12/22/20 Sorrento Therapeutics submits EUA to FDA for COVI-STIX rapid test SRNE Sorrento Therapeutics $10.27 / +0.98 (+10.55%) 01/21/21 Alliance Global Partners Sorrento Therapeutics initiated with a Buy at Alliance Global Partners 07/31/20 H.C. Wainwright Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright 07/20/20 Dawson James Sorrento antibody cocktail effort could move quickly, says Dawson James 05/26/20 Dawson James Sorrento Therapeutics initiated with a Buy at Dawson James SRNE Sorrento Therapeutics $10.27 / +0.98 (+10.55%) 01/19/21 Fly Intel: After-Hours Movers 12/23/20 Fly Intel: Wall Street's top stories for Wednesday 12/23/20 Fly Intel: Wall Street's top stories at midday 11/27/20 Fly Intel: Pre-market Movers SRNE Sorrento Therapeutics $10.27 / +0.98 (+10.55%) 01/14/21 Sorrento Therapeutics call volume above normal and directionally bullish 12/23/20 Sorrento Therapeutics call volume above normal and directionally bullish 12/10/20 Sorrento Therapeutics call volume above normal and directionally bullish 12/09/20 Unusually active option classes on open December 9th
Recommendations	BAWAG Group price target lowered to EUR 43 from EUR 44 at JPMorgan » 13:24 01/26/21 01/26 13:24 01/26/21 13:24 BWAGF BAWAG Group $0.00 / + (+0.00%) JPMorgan analyst Samuel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BWAGF BAWAG Group $0.00 / + (+0.00%) 10/16/20 Credit Suisse BAWAG Group initiated with an Outperform at Credit Suisse 05/22/20 JPMorgan BAWAG Group price target lowered to EUR 42 from EUR 45 at JPMorgan 04/28/20 Morgan Stanley BAWAG Group price target lowered to EUR 39 from EUR 51 at Morgan Stanley
Periodicals	French President Macron warns Big Tech to obey EU rules, Bloomberg says » 13:24 01/26/21 01/26 13:24 01/26/21 13:24 GOOG Alphabet $1,913.00 / +12.93 (+0.68%) , GOOGL Alphabet Class A $1,903.84 / +9.25 (+0.49%) , MSFT Microsoft $232.39 / +2.91 (+1.27%) France is getting very… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GOOG GOOGL MSFT GOOG Alphabet $1,913.00 / +12.93 (+0.68%) 12:40 Today YouTube saw 25% boost in watchtime around the world in 1Q20 12:38 Today YouTube says it removed over half a million COVID-19 misinformation videos 11:38 Today User reports indicate Google, gmail having issues, says DownDetector 06:13 Today Elon Musk says Tesla 'has better AI hardware and software than Waymo' GOOGL Alphabet Class A $1,903.84 / +9.25 (+0.49%) 12:40 Today YouTube saw 25% boost in watchtime around the world in 1Q20 12:38 Today YouTube says it removed over half a million COVID-19 misinformation videos 11:38 Today User reports indicate Google, gmail having issues, says DownDetector 06:13 Today Elon Musk says Tesla 'has better AI hardware and software than Waymo' MSFT Microsoft $232.39 / +2.91 (+1.27%) 01/25/21 LinkedIn names Dan Shapero as first ever COO 01/22/21 Microsoft increases pricing for Xbox Live Gold 01/22/21 SAP, Microsoft expand partnership 01/20/21 EU fines Valve, Capcom, ZeniMax, others EUR7.8M for 'geo-blocking' practices GOOG GOOGL MSFT GOOG Alphabet $1,913.00 / +12.93 (+0.68%) 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value 01/25/21 Canaccord Alphabet price target raised to $2250 from $2050 at Canaccord 01/25/21 Mizuho Alphabet price target raised to $2,100 from $1,810 at Mizuho 01/21/21 Fly Intel: Top five analyst initiations GOOGL Alphabet Class A $1,903.84 / +9.25 (+0.49%) 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value 01/25/21 Mizuho Alphabet price target raised to $2,100 from $1,810 at Mizuho 01/21/21 Fly Intel: Top five analyst initiations 01/20/21 Piper Sandler Alphabet assumed with an Overweight at Piper Sandler MSFT Microsoft $232.39 / +2.91 (+1.27%) 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value 01/25/21 DA Davidson Box downgraded to Neutral from Buy at DA Davidson 01/22/21 RBC Capital Varonis price target raised to $200 from $165 at RBC Capital 01/21/21 Goldman Sachs Microsoft initiated with a Buy at Goldman Sachs GOOG GOOGL MSFT GOOG Alphabet $1,913.00 / +12.93 (+0.68%) 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago 10/29/20 Alphabet reports Q3 EPS $16.40, consensus $11.29 GOOGL Alphabet Class A $1,903.84 / +9.25 (+0.49%) 10/29/20 Alphabet CFO sees signs user behavior beginning to return to normalized level 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago MSFT Microsoft $232.39 / +2.91 (+1.27%) 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B 10/27/20 Microsoft reports Q1 EPS $1.82, consensus $1.54 10/27/20 Notable companies reporting after market close GOOG GOOGL MSFT GOOG Alphabet $1,913.00 / +12.93 (+0.68%) 06:19 Today Google stops donations to Congress members againstelection results, Reuters says 06:10 Today EU examining Google's data gathering, adtech practices, BI reports 01/23/21 Big tech stocks are back, Barron's says 01/22/21 YouTube enables HDR support on Xbox gaming systems, Verge reports GOOGL Alphabet Class A $1,903.84 / +9.25 (+0.49%) 06:19 Today Google stops donations to Congress members againstelection results, Reuters says 06:10 Today EU examining Google's data gathering, adtech practices, BI reports 01/23/21 Big tech stocks are back, Barron's says 01/22/21 YouTube enables HDR support on Xbox gaming systems, Verge reports MSFT Microsoft $232.39 / +2.91 (+1.27%) 01/22/21 YouTube enables HDR support on Xbox gaming systems, Verge reports 01/19/21 FireEye releases tool for auditing networks after SolarWinds hack, ZDNet says 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/13/21 Lucasfilm partners with Ubisoft to make open-world 'Star Wars' game, Wired says GOOG GOOGL MSFT GOOG Alphabet $1,913.00 / +12.93 (+0.68%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler GOOGL Alphabet Class A $1,903.84 / +9.25 (+0.49%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler MSFT Microsoft $232.39 / +2.91 (+1.27%) 12:30 Today Game On: GameStop continues puzzling surge 01/25/21 GameStop jumps above $100 in volatile trading despite double downgrade to sell 01/22/21 Disney, Ford upgrades among today's top calls on Wall Street 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 00:00 Today Pharmacovigilance & Risk Management Strategies Virtual Conference 02/11/21 Technology & Internet Virtual Conference 17:30 Today Microsoft - MSFT 02/02/21 Alphabet Class A - GOOGL 02/02/21 Alphabet - GOOG GOOG GOOGL MSFT GOOG Alphabet $1,913.00 / +12.93 (+0.68%) 11/10/20 Alphabet call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th GOOGL Alphabet Class A $1,903.84 / +9.25 (+0.49%) 01/20/21 Early notable gainers among liquid option names on January 20th 10/30/20 Early notable gainers among liquid option names on October 30th 10/21/20 Unusually active option classes on open October 21st 08/27/20 Alphabet Class A call volume above normal and directionally bullish MSFT Microsoft $232.39 / +2.91 (+1.27%) 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th 10/28/20 Notable open interest changes for October 28th 10/27/20 Notable open interest changes for October 27th
Recommendations	Telia price target raised to SEK 38 from SEK 37 at JPMorgan » 13:23 01/26/21 01/26 13:23 01/26/21 13:23 TLSNY Telia $0.00 / + (+0.00%) JPMorgan analyst Roman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research TLSNY Telia $0.00 / + (+0.00%) 11/04/20 Credit Suisse Telia price target raised to SEK 29.50 from SEK 28 at Credit Suisse 10/30/20 Barclays Telia price target raised to SEK 46 from SEK 45 at Barclays 10/22/20 JPMorgan Telia price target lowered to SEK 37 from SEK 37.50 at JPMorgan 10/19/20 JPMorgan Telia price target raised to SEK 37.50 from SEK 35 at JPMorgan
Recommendations	Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan » 13:20 01/26/21 01/26 13:20 01/26/21 13:20 PHG Philips $57.60 / +0.61 (+1.07%) JPMorgan analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PHG Philips $57.60 / +0.61 (+1.07%) 01/25/21 Philips' Stellarex drug-coated balloon meets safety goals in two studies 01/25/21 Philips, Rennes University Hospital announce five-year partnership 01/25/21 Philips, Vithas Group enter five-year innovation and collaboration agreement 01/19/21 Philips to acquire Capsule Technologies for $635M in cash, sees accretion PHG Philips $57.60 / +0.61 (+1.07%) 12:45 Today UBS Philips price target raised to EUR 54 from EUR 51 at UBS 01/25/21 Morgan Stanley iRhythm price target raised to $288 from $227 at Morgan Stanley 01/20/21 Berenberg Philips price target raised to EUR 50 from EUR 49 at Berenberg 01/19/21 JPMorgan Philips price target raised to EUR 44 from EUR 39.40 at JPMorgan PHG Philips $57.60 / +0.61 (+1.07%) 01/25/21 Philips reports Q4 adjusted EPS EUR 0.94 vs. EUR 0.83 last year 10/19/20 Philips reports Q3 adj. EPS EUR 0.60 vs. EUR 0.46 last year PHG Philips $57.60 / +0.61 (+1.07%) 01/05/21 Philips shortlists Asian suitors in home appliance unit sale, Bloomberg says PHG Philips $57.60 / +0.61 (+1.07%) 01/25/21 Fly Intel: Pre-market Movers 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers 03/02/21 2021 London Global Healthcare Virtual Conference

Recommendations	Kion Group price target raised to EUR 66 from EUR 63.50 at JPMorgan » 13:19 01/26/21 01/26 13:19 01/26/21 13:19 KIGRY Kion Group $0.00 / + (+0.00%) JPMorgan analyst Akash… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KIGRY Kion Group $0.00 / + (+0.00%) 01/15/21 Morgan Stanley Kion Group price target raised to EUR 68 from EUR 64 at Morgan Stanley 01/12/21 Deutsche Bank Kion Group price target raised to EUR 75 from EUR 70 at Deutsche Bank 12/08/20 Berenberg Kion Group price target lowered to EUR 81 from EUR 86 at Berenberg 12/07/20 Deutsche Bank Kion Group price target lowered to EUR 70 from EUR 78 at Deutsche Bank
Recommendations	Hermes price target raised to EUR 635 from EUR 540 at JPMorgan » 13:18 01/26/21 01/26 13:18 01/26/21 13:18 HESAY Hermes $0.00 / + (+0.00%) JPMorgan analyst Melanie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HESAY Hermes $0.00 / + (+0.00%) 12/11/20 Bernstein Hermes downgraded to Market Perform from Outperform at Bernstein 12/07/20 UBS Hermes price target raised to EUR 924 from EUR 880 at UBS 10/23/20 UBS Hermes price target raised to EUR 880 from EUR 811 at UBS 10/23/20 Morgan Stanley Hermes price target raised to EUR 735 from EUR 670 at Morgan Stanley
Recommendations	Airbus price target raised to EUR 109 from EUR 101 at JPMorgan » 13:17 01/26/21 01/26 13:17 01/26/21 13:17 EADSY Airbus $0.00 / + (+0.00%) JPMorgan analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly EADSY Airbus $0.00 / + (+0.00%) 01/25/21 Frontier Airlines selects Pratt & Whitney GTF Engines to power Airbus aircraft 01/21/21 Airbus says plane production rates will remain lower for longer 01/11/21 Air Lease reports Q4 aircraft investments 01/08/21 Airbus signs multi-satellite contract with Intelsat for OneSat satellites EADSY Airbus $0.00 / + (+0.00%) 01/21/21 Jefferies Airbus production update includes 'good news' on A350, says Jefferies 01/12/21 Berenberg Airbus price target raised to EUR 110 from EUR 80 at Berenberg 01/11/21 JPMorgan Airbus upgraded to Overweight from Neutral at JPMorgan 12/31/20 Jefferies Airbus may face additional disruption from U.S. tariffs, says Jefferies EADSY Airbus $0.00 / + (+0.00%) 10/29/20 Airbus reports 9-month EPS EUR (3.43) vs. EUR 2.81 last year 07/30/20 Airbus reports H1 EPS EUR (1.01) vs. EUR 2.25 last year EADSY Airbus $0.00 / + (+0.00%) 01/03/21 Airbus said to deliver about 560 planes last year, Bloomberg reports 12/31/20 U.S. amends duties on EU goods in Airbus, Boeing dispute, Bloomberg says 12/29/20 Airbus hands over 550 aircraft in 2020, Bloomberg reports 12/22/20 Airbus to lose over $5B in orders if AAX debt scheme goes through, Reuters says EADSY Airbus $0.00 / + (+0.00%) 01/02/21 Week in review: How Trump's policies moved stocks 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/31/20 Fly Intel: Wall Street's top stories at midday 11/18/20 Boeing rises after FAA lifts order grounding 737 MAX
Technical Analysis	NASDAQ market internals summary » 13:17 01/26/21 01/26 13:17 01/26/21 13:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 01/25/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 13:16 01/26/21 01/26 13:16 01/26/21 13:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 01/25/21 NYSE market internals summary

General news	FOMC began its 2-day meeting » 13:15 01/26/21 01/26 13:15 01/26/21 13:15 FOMC began its 2-day… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	Treasury's record $61 B 5-year auction results were mixed » 13:15 01/26/21 01/26 13:15 01/26/21 13:15 Treasury's record… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	52-Week Bill Auction Bid/Cover data reported » 13:09 01/26/21 01/26 13:09 01/26/21 13:09 52-Week Bill Auction… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	52-Week Bill Auction Total Amount data reported » 13:09 01/26/21 01/26 13:09 01/26/21 13:09 52-Week Bill Auction… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	5-Yr Note Auction Coupon Rate data reported » 13:09 01/26/21 01/26 13:09 01/26/21 13:09 5-Yr Note Auction Coupon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

General news	5-Yr Note Auction Total Amount data reported » 13:08 01/26/21 01/26 13:08 01/26/21 13:08 5-Yr Note Auction Total… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Options	Hyliion Holdings call volume above normal and directionally bullish » 13:05 01/26/21 01/26 13:05 01/26/21 13:05 HYLN Hyliion Holdings $19.49 / +2.27 (+13.18%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events Options HYLN Hyliion Holdings $19.49 / +2.27 (+13.18%) 01/12/21 Hyliion Holdings announces Sherri Baker as CFO, succeeding Greg Van de Vere 12/30/20 Hyliion 'applauds' extension of Alternative Fuels Tax Credit 12/16/20 Hyliion Holdings rises 5.2% 11/30/20 Hyliion Holdings falls -14.6% HYLN Hyliion Holdings $19.49 / +2.27 (+13.18%) 12/16/20 Barclays Hyliion Holdings initiated with an Overweight at Barclays 10/28/20 Fly Intel: Top five analyst initiations 10/28/20 JPMorgan Hyliion Holdings initiated with a Neutral at JPMorgan 10/15/20 Goldman Sachs Hyliion Holdings initiated with a Neutral at Goldman Sachs HYLN Hyliion Holdings $19.49 / +2.27 (+13.18%) 11/12/20 Hyliion Holdings reports Q3 EPS (76c), one estimate (86c) HYLN Hyliion Holdings $19.49 / +2.27 (+13.18%) 10/17/20 Investors should handle EV-SPAC deals with care, Barron's says 10/16/20 Bonitas Research issues cautious note on Hyliion Holdings 02/11/21 Technology & Internet Virtual Conference HYLN Hyliion Holdings $19.49 / +2.27 (+13.18%) 01/21/21 Hyliion Holdings call volume above normal and directionally bullish 01/07/21 Hyliion Holdings call volume above normal and directionally bullish 12/23/20 Hyliion Holdings call volume above normal and directionally bullish 12/17/20 Largest borrow rate increases among liquid names
Periodicals	Biden to limit government's use of private prisons, Reuters reports » 13:01 01/26/21 01/26 13:01 01/26/21 13:01 GEO Geo Group $7.75 / -0.29 (-3.61%) , CXW CoreCivic $6.40 / -0.26 (-3.90%) President Joe Biden plans… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options GEO CXW GEO Geo Group $7.75 / -0.29 (-3.61%) 01/20/21 Geo Group's contract for Moshannon Valley facility not renewed 12/15/20 NY AG James takes action to force GEO to comply with ongoing investigation 11/23/20 Geo Group: FBP declines to rebid contract for Rivers Correctional Facility 11/13/20 MGIC Investment to replace Geo Group in S&P 400 at open on 11/13 CXW CoreCivic $6.40 / -0.26 (-3.90%) 01/06/21 CoreCivic falls -6.2% 12/23/20 CoreCivic sells 42 government leased properties for $106.5M 11/04/20 CoreCivic falls -9.5% 10/21/20 CoreCivic announces support for Pell Grant restoration GEO CXW GEO Geo Group $7.75 / -0.29 (-3.61%) 06/29/20 Noble Capital Geo Group initiated with an Outperform at Noble Capital CXW CoreCivic $6.40 / -0.26 (-3.90%) 03/16/20 Noble Capital CoreCivic initiated with an Outperform at Noble Capital GEO CXW GEO Geo Group $7.75 / -0.29 (-3.61%) 10/29/20 Geo Group sees Q4 adjusted FFO 55c-58c, consensus 52c 10/29/20 Geo Group raises FY20 adjusted FFO view to $2.43-$2.45 from $2.29-$2.33 10/29/20 Geo Group reports Q3 adjusted FFO 67c, consensus 60c 08/06/20 Geo Group sees Q3 adjusted FFO 58c-60c, consensus 57c CXW CoreCivic $6.40 / -0.26 (-3.90%) 11/04/20 CoreCivic does not see issuing guidance until it has more clarity 11/04/20 CoreCivic reports Q3 adjusted EPS 28c, one estimate 22c 03/15/21 33rd Annual Roth Virtual Conference GEO CXW GEO Geo Group $7.75 / -0.29 (-3.61%) 12/03/20 GEO Group put volume heavy and directionally bearish 11/03/20 GEO Group call volume above normal and directionally bullish 11/02/20 GEO Group call volume above normal and directionally bullish CXW CoreCivic $6.40 / -0.26 (-3.90%) 11/02/20 CoreCivic call volume above normal and directionally bullish
Upgrade	LexinFintech upgraded to Buy from Outperform at CLSA » 12:57 01/26/21 01/26 12:57 01/26/21 12:57 LX LexinFintech $7.32 / +0.15 (+2.09%) CLSA analyst Ethan Wang… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options LX LexinFintech $7.32 / +0.15 (+2.09%) 01/25/21 LexinFintech sees FY21 loan originations RMB 220B-RMB 230B 11/04/20 LexinFintech provides update on discussion draft regulatory development 09/14/20 LexinFintech announces management share purchase plan LX LexinFintech $7.32 / +0.15 (+2.09%) 06/16/20 China Renaissance China Renaissance ups LexinFintech to Buy, raises Fintech sector to Overweight 06/15/20 China Renaissance LexinFintech upgraded to Buy from Hold at China Renaissance 06/09/20 Citi LexinFintech upgraded to Buy following pullback at Citi 06/09/20 Citi LexinFintech upgraded to Buy from Neutral at Citi LX LexinFintech $7.32 / +0.15 (+2.09%) 08/18/20 LexinFintech reports Q2 EPS 30c, consensus 32c LX LexinFintech $7.32 / +0.15 (+2.09%) 08/25/20 LexinFintech a 'leverage time bomb,' short-seller Grizzly Research says LX LexinFintech $7.32 / +0.15 (+2.09%) 08/13/20 Largest borrow rate increases among liquid names
Recommendations	Siemens Energy price target raised to EUR 37 from EUR 35 at Deutsche Bank » 12:52 01/26/21 01/26 12:52 01/26/21 12:52 SMEGF Siemens Energy $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SMEGF Siemens Energy $0.00 / + (+0.00%) 01/15/21 Morgan Stanley Siemens Energy price target raised to EUR 33 from EUR 29 at Morgan Stanley 01/12/21 Deutsche Bank Siemens Energy price target raised to EUR 35 from EUR 30 at Deutsche Bank 12/09/20 Deutsche Bank Siemens Energy price target raised to EUR 30 from EUR 27 at Deutsche Bank 12/07/20 JPMorgan Siemens Energy price target raised to EUR 28 from EUR 26 at JPMorgan

Events

Earnings calls, analyst events, roadshows and more

PFBC
Today at 14:00

Preferred Bank - PFBC Conference Calls
RBB
Today at 14:00

RBB Bancorp - RBB Conference Calls
SNGX
Today at 14:30

Soligenix - SNGX Conference Calls
SNGX
Today at 14:30

Soligenix - SNGX Conference Calls
GSBC
Today at 15:00

Great Southern Bancorp - GSBC Conference Calls
CAC
Today at 15:00

Camden National - CAC Conference Calls
Today at 15:00

Consumer Goods Industry Meetings
Today at 15:00

Healthcare Industry Meetings
SMBC
Today at 16:30

Southern Missouri Bancorp - SMBC Conference Calls
CNI
Today at 16:30

Canadian National - CNI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $22.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares
Fri	No deals

View All Syndicate Announcements »

Genprex initiates site recruitment for Acclaim-1 clinical trial

TODAY'S FREE FLY STORIES

Get Full Fly Access